Financing, Equity Capital Markets

Matinas BioPharma Holdings, Inc.

01/20
|
$50.0 Million
Piper Sandler served as left bookrunner for Matinas BioPharma Holdings on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma